Thymogen is a short peptide bioregulator developed within the Khavinson school of peptide research at the Saint Petersburg Institute of Bioregulation and Gerontology. Classified as a synthetic dipeptide with the sequence L-glutamyl-L-tryptophan (Glu-Trp, EW), Thymogen was developed to investigate how minimal peptide sequences interact with thymus-associated immune cells and lymphoid tissue research models. Its compact structure positions Thymogen as a useful research compound for studying tissue-specific peptide signaling in laboratory contexts.
At the cellular and molecular level, Thymogen is studied for its proposed ability to engage with thymic-tropic signaling pathways and modulate transcriptional activity within T-lymphocyte and macrophage cell models. Research observations within the Khavinson framework suggest that short bioregulator peptides interact with specific DNA regions to influence the expression of genes associated with thymic hormone synthesis, lymphocyte differentiation, and immune-cell cytokine output. These observations are consistent with the broader proposition that short peptides act as gene-expression regulators within tissues from which their parent peptide complexes were originally extracted.
Research interest in Thymogen centers on thymus-tissue gene expression studies, lymphocyte differentiation research models, and immune-cell cytokine investigations. Comparative work on tissue-specific bioregulators positions Thymogen alongside other immune-targeted oligopeptides used to explore peptidergic regulation of thymic biology in cell-culture and animal research models (Khavinson V.K., Anisimov V.N., 2009, Advances in Gerontology). Additional reports within the Khavinson tradition describe how the Glu-Trp sequence influences T-cell differentiation, cytokine signaling, and lymphocyte chromatin organization in immune research models, supporting continued laboratory investigation of Thymogen in thymic and immune-cell biology research.
The peptide is supplied as a lyophilized powder to ensure optimal stability during storage and handling.
See also: Crystagen 20 mg, Vilon 20 mg, and Testagen.
Specifications
- Purity: 99%
- Quantity: 20 mg
- CAS Number: 38101-59-6
- Molecular Formula: C₁₆H₁₉N₃O₅
- Molecular Weight: 333.34 g/mol




Reviews
There are no reviews yet.